JANL director acquires 2,500 options at $36.01 — 10/01/2025
Gregory J. Melsen, a director of JANEL CORP (ticker JANL), reported an acquisition on 10/01/2025 of a stock option giving the right to buy 2,500 shares of common stock at a conversion/exercise price of $36.01.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Gregory J. Melsen, a director of JANEL CORP (ticker JANL), reported an acquisition on 10/01/2025 of a stock option giving the right to buy 2,500 shares of common stock at a conversion/exercise price of $36.01. The option becomes exercisable on 12/31/2028 and expires on 09/30/2035. Following the reported transaction, Mr. Melsen directly beneficially owns 2,500 shares/options as disclosed on the Form 4.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 2,500 | $0.00 | $0.00 |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What transaction did JANL director Gregory Melsen report on Form 4?
What is the exercise price and exercisable/expiration dates for the option?
What is the reporting date and signature date on the Form 4?
What is Mr. Melsen's relationship to JANL?
AI-generated analysis. How Rhea-AI works. Not financial advice.